Detail
| LncRNA Name | LINC00520 |
| Synonyms | LINC00520, C14orf34 |
| Region | GRCh38_14:55781135-55796688 Sequence |
| Ensembl | ENSG00000258791 |
| RefSeq | NR_026796 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | RNA-seq, qPCR, RNAi etc. |
| Sample | cell lines (MCF-7, and MDA-MB-468, MDA-MB-453, MDA-MB-231 etc.) |
| Expression Pattern | up-regulated |
| Function Description | LINC00520 is elevated in a subset of human breast carcinomas, with preferential enrichment in the basal-like molecular subtype. ShRNA-mediated depletion of LINC00520 results in decreased cell migration and loss of invasive structures in 3D. |
| Pubmed ID | 27626181 |
| Year | 2016 |
| Title | LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. |
| External Links |
| Links for LINC00520 | GenBank HGNC lncrnadb Noncode |
| Links for breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.